Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma

NCT00003490 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

BIOLOGICAL: sargramostim
DRUG: cyclophosphamide
DRUG: prednisone
DRUG: vincristine sulfate

Sponsor

The Cleveland Clinic